✦ LIBER ✦

1045 SAFETY AND ANTIVIRAL EFFICACY OF 14 DAYS OF THE CYCOPHILIN INHIBITOR NIM811 IN COMBINATION WITH PEGYLATED INTERFERON α2a IN RELAPSED GENOTYPE 1 HCV INFECTED PATIENTS

✍ Scribed by Lawitz, E.; Rouzier, R.; Nguyen, T.; Huang, M.; Ke, J.; Praestgaard, J.; Serra, D.; Koziel, M.; Evans, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, pharmacokinetics, and antiviral

✍ Eric Lawitz; Eliot Godofsky; Regine Rouzier; Thomas Marbury; Tuan Nguyen; June K 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 620 KB

2009 SAFETY AND ANTIVIRAL ACTIVITY OF AN

✍ Lawitz, E.; Rodriquez-Torres, M.; Rustgi, V.K.; Hassanein, T.; Rahimy, M.H.; Cro 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

1052 ANTIVIRAL ACTIVITY OF FILIBUVIR IN

✍ Jacobson, I.; Pockros, P.; Lalezari, J.; Lawitz, E.; Rodriguez-Torres, M.; DeJes 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

95 EFFICACY AND SAFETY OF THE CYCLOPHILI

✍ D.R. Nelson; R.H. Ghalib; M. Sulkowski; E. Schiff; V. Rustgi; P.J. Pockros; C. W 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

143 EFFICACY AND SAFETY OF INCREASING DO

✍ R. Flisiak; S.V. Feinman; M. Jablkowski; A. Horban; W. Kryczka; W. Halota; J.E. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Steatosis is the predictor of relapse in

✍ L. Restivo; R. Zampino; B. Guerrera; L. Ruggiero; L. E. Adinolfi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB